122 related articles for article (PubMed ID: 38706448)
1. Clinical characteristics of acute myeloid leukaemia patients with a large number of azurophilic granules: A single-centre retrospective study.
Zhao S; Wang J; Lou Y; Huang X; Xie W; Yu W; Liu L; Zhu Y; Gao X; Ma G; Zhou Z; Ghoushi E; Ghafouri M; Jin J; Tong H; Zhou D
Br J Haematol; 2024 May; ():. PubMed ID: 38706448
[TBL] [Abstract][Full Text] [Related]
2. CD34 negative HLA-DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3-ITD mutations.
Gajendra S; Gupta R; Thakral D; Gupta SK; Jain G; Bakhshi S; Sharma A; Sahoo RK; Kumar L; Rai S; Singh S; Upadhyay AD
Int J Lab Hematol; 2023 Apr; 45(2):221-228. PubMed ID: 36504282
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterisation of
Kloppers JF; de Kock A; Cronjé J; van Marle AC
Afr J Lab Med; 2021; 10(1):1363. PubMed ID: 34230878
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia - preliminary report.
Helbig G; Wozniczka K; Wieclawek A; Soja A; Bartkowska-Chrobok A; Kyrcz-Krzemien S
Contemp Oncol (Pozn); 2014; 18(4):241-5. PubMed ID: 25258581
[TBL] [Abstract][Full Text] [Related]
5. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
Ghosh K; Swaminathan S; Madkaikar M; Gupta M; Kerketta L; Vundinti B
Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of FLT3-ITD mutation on NPM1
Pan X; Chang Y; Ruan G; Wei F; Jiang H; Jiang Q; Huang X; Zhao X
Br J Haematol; 2023 Oct; 203(2):212-223. PubMed ID: 37621257
[TBL] [Abstract][Full Text] [Related]
7. Incidence and clinical significance of FLT3 and nucleophosmin mutation in childhood acute myeloid leukemia in Chile.
Cabrera ME; Monardes V; Salgado C; Cares C; Gonzalez C
Hematol Transfus Cell Ther; 2023; 45(1):77-82. PubMed ID: 34690101
[TBL] [Abstract][Full Text] [Related]
8. Clinico-Haematologic association and prognostic relevance of NPM1 and FLT3-ITD mutations in acute Myeloid Leukaemia.
Mahmood R; Altaf C; Malik HS; Khan SA
Pak J Med Sci; 2019; 35(1):23-28. PubMed ID: 30881390
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia.
Scholl S; Theuer C; Scheble V; Kunert C; Heller A; Mügge LO; Fricke HJ; Höffken K; Wedding U
Eur J Haematol; 2008 Mar; 80(3):208-15. PubMed ID: 18081718
[TBL] [Abstract][Full Text] [Related]
10. [Association of Next Generation Sequencing Based Genotypic Profiling with MICM Characteristics in NPM1 Mutated Acute Myeloid Leukemia].
Wang B; Ling Y; Dai L; Gu WY; Zhang XW; Xing SS; Li HQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):56-60. PubMed ID: 35123604
[TBL] [Abstract][Full Text] [Related]
11. Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.
Cortes J; Perl AE; Döhner H; Kantarjian H; Martinelli G; Kovacsovics T; Rousselot P; Steffen B; Dombret H; Estey E; Strickland S; Altman JK; Baldus CD; Burnett A; Krämer A; Russell N; Shah NP; Smith CC; Wang ES; Ifrah N; Gammon G; Trone D; Lazzaretto D; Levis M
Lancet Oncol; 2018 Jul; 19(7):889-903. PubMed ID: 29859851
[TBL] [Abstract][Full Text] [Related]
12. Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML.
Ahn JS; Kim HJ; Kim YK; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Ann Hematol; 2016 Mar; 95(4):625-35. PubMed ID: 26692090
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Clinical Significance of FLT3 and NPM1 Mutations in Acute Myeloid Leukaemia Patients of Assam, India.
Bhattacharyya J; Nath S; Saikia KK; Saxena R; Sazawal S; Barman MP; Kumar D
Indian J Hematol Blood Transfus; 2018 Jan; 34(1):32-42. PubMed ID: 29398797
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics of newly diagnosed acute myeloid leukemia patients with NPM1 mutation].
Wei H; Zhang YQ; Lin D; Wang Y; Zhou CL; Liu BC; Li W; Rao Q; Wang M; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):11-5. PubMed ID: 24598642
[TBL] [Abstract][Full Text] [Related]
15. FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia.
Arrigoni P; Beretta C; Silvestri D; Rossi V; Rizzari C; Valsecchi MG; Cazzaniga G; Biondi A
Br J Haematol; 2003 Jan; 120(1):89-92. PubMed ID: 12492581
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France.
Alcazer V; Le Meur G; Roccon M; Barriere S; Le Calvez B; Badaoui B; Spaeth A; Kosmider O; Freynet N; Eveillard M; Croizier C; Chevalier S; Sujobert P
Lancet Digit Health; 2024 May; 6(5):e323-e333. PubMed ID: 38670741
[TBL] [Abstract][Full Text] [Related]
17. [A study of NPM1 and FLT3 gene mutations in acute myeloid leukemia].
Wu DP; Yan LZ; Yang L; Chen SN; Wu XJ; Liang JY
Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):907-10. PubMed ID: 18261272
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
19. Incidence and significance of FLT3-ITD and NPM1 mutations in patients with normal karyotype acute myeloid leukaemia.
Haslam K; Chadwick N; Kelly J; Browne P; Vandenberghe E; Flynn C; Conneally E; Langabeer SE
Ir J Med Sci; 2010 Dec; 179(4):507-10. PubMed ID: 20803351
[TBL] [Abstract][Full Text] [Related]
20. Identification of FLT3 and NPM1 Mutations in Patients with Acute Myeloid Leukaemia.
Mat Yusoff Y; Abu Seman Z; Othman N; Kamaluddin NR; Esa E; Zulkiply NA; Abdullah J; Zakaria Z
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1749-1755. PubMed ID: 31244296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
